National and state datasets are used to evaluate cost and utilization in populations (Medicare, Medicaid and Commercial) including utilization of inpatient, ED, outpatient and pharmacy visits, avoidable visits and costs, disease prevalence, drug adherence and drug product use by disease and demographic groups which can be used internally and/or for external audiences.
Advanced analytics platform integrates client specific and external data to generate insights, answer specific questions, identify barriers, evaluate reimbursement and profitability and develop market channel, segment and payer penetration and expansion strategies.
Development of partnerships between industry and other healthcare entities including payers, providers, vendors, patient advocacy organizations and other stakeholders.
Data aggregation, exchange and integration technology solutions
Drug rebate validation and recoupments
Health outcomes and pharmacoeconomic research and publications
PA criteria development and auditing
340B and drug pricing and reimbursement audits
Comprehensive medication management, patient engagement and adherence programs using our proprietary tools and technologies
Population health program development including design, operations, evaluations with VBC contracting
Technology and vender evaluations and oversight
Grant and RFP response, reviews and contract evaluations